Myelodysplastic Syndromes
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndromes.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-02-03Clinical Trial Update: Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment [Phase 2]
Phase 2 trial evaluating cyproheptadine and megestrol to prevent weight loss in children with cancer-related cachexia; the study has complet…
-
CLINICAL_TRIALS trial_result · 2014-01-27Clinical Trial Update: Platelet Response During the Second Cycle of Decitabine Can Predict Response and Survival for Myelodysplastic Syndrome
This clinical trial update reports that platelet response during the second cycle of decitabine may predict treatment response and survival …
-
FDA approval · 2014-01-23FDA Approved: DECITABINE — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries' original application for decitabine. The drug is used to treat myelodysplastic syndromes and…
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: Allogeneic Hematopoietic Stem Cell Transplantation Evaluation in High Risk Myelodysplasia: an Observational Non-interventional Study
An observational, non-interventional study evaluating allogeneic hematopoietic stem cell transplantation for high-risk myelodysplastic syndr…
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases [Phase 2]
Phase 2 clinical trial evaluating umbilical cord blood stem cell transplantation for treating malignant and nonmalignant diseases in young p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-01-08Clinical Trial Update: T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating T-cell depleted donor lymphocyte infusion for acute myeloid leukemia and high-risk myelodysplastic syndr…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Vaccine Therapy and GM-CSF in Treating Patients With Low-Risk or Intermediate-Risk Myelodysplastic Syndrome [Phase 2]
Phase 2 clinical trial evaluating vaccine therapy with GM-CSF for low- or intermediate-risk myelodysplastic syndrome. The document provides …
-
CLINICAL_TRIALS research · 2014-01-06Clinical Trial Update: Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders [Phase 2]
Phase 2 clinical trial evaluating chemotherapy followed by donor bone marrow or peripheral stem cell transplantation in patients with hemato…
-
CLINICAL_TRIALS research · 2014-01-06Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia [NA]
This entry discusses donor stem cell transplantation as a treatment option for patients with hematologic cancers, metastatic kidney cancer, …
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Gemtuzumab in Treating Patients With Myelodysplastic Syndrome [Phase 2]
This update reports on a Phase 2 clinical trial evaluating gemtuzumab ozogamicin for myelodysplastic syndromes.
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer [Phase 1]
This is a Phase 1 clinical trial update evaluating the combination of chemotherapy with amifostine in patients with advanced cancer.
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer [Phase 2]
This Phase 2 trial evaluated donor stem cell transplantation for high-risk hematologic cancers. The study status is terminated and results w…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 3]
Phase 3 trial comparing intensive versus nonintensive chemotherapy in older adults with acute myeloid leukemia or myelodysplastic syndromes.…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia [Phase 2]
Phase 2 clinical trial evaluating umbilical cord blood and placental blood transplantation for hematologic cancers or aplastic anemia. The s…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic Syndromes [Phase 1]
A Phase 1 trial evaluating the combination of 5-azacitidine and lenalidomide in myelodysplastic syndromes and acute myeloid leukemia was ter…
-
CLINICAL_TRIALS trial_result · 2013-12-17Clinical Trial Update: Study of CC-5013 to Evaluate Safety, Pharmacokinetics and Effectiveness for Japanese Patients With Symptomatic Anemia Associated With Myelodysplastic Syndrome With a Del(5)(q31-33) Abnormality. [Phase 2]
Phase 2 trial evaluating CC-5013 (lenalidomide) in Japanese patients with symptomatic anemia due to myelodysplastic syndrome with del(5)(q31…
-
CLINICAL_TRIALS research · 2013-12-17Clinical Trial Update: A Phase Ⅳ Study of Decitabine in Myelodysplastic Syndrome [Phase 4]
This clinical trial update discusses a Phase 4 study of decitabine in myelodysplastic syndromes, with the trial status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation [Phase 2]
Phase 2 trial evaluating sirolimus, tacrolimus, thymoglobulin, and rituximab as graft-versus-host-disease prophylaxis in haploidentical and …
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Transplantation [Phase 1]
A Phase I study evaluating WT1 peptide immunotherapy to induce anti-leukemia immune responses after transplantation was terminated.
-
CLINICAL_TRIALS trial_result · 2013-12-06Clinical Trial Update: Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes [Phase 3]
Phase 3 trial comparing erythropoietin with or without filgrastim to supportive therapy alone in myelodysplastic syndromes; results posted i…
-
CLINICAL_TRIALS trial_result · 2013-12-05Clinical Trial Update: MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia [Phase 1]
Phase 1 clinical trial update showing results for MLN4924 (pevonedistat) in acute myeloid leukemia, acute lymphoblastic leukemia, and myelod…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome [Phase 2]
An update on a Phase 2 clinical trial of combination chemotherapy for patients with myelodysplastic syndromes, sponsored by ALZA.
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia [Phase 3]
A Phase 3 trial comparing combination chemotherapy with or without bone marrow transplantation in children with acute myeloid leukemia. The …
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic Syndromes [Phase 2]
Phase 2 trial evaluating azacitidine with lintuzumab in previously untreated myelodysplastic syndromes was terminated after results were pos…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Phase 2 Study of Telintra® in Deletion 5q Myelodysplastic Syndrome [Phase 2]
Phase 2 study of Telintra (TLK199) in patients with deletion 5q myelodysplastic syndrome has been terminated.